Home/Filings/4/0001209191-23-041107
4//SEC Filing

Harsch Mutya 4

Accession 0001209191-23-041107

CIK 0001566044other

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 4:32 PM ET

Size

5.1 KB

Accession

0001209191-23-041107

Insider Transaction Report

Form 4
Period: 2023-06-30
Harsch Mutya
CHIEF LEGAL OFFICER AND GC
Transactions
  • Tax Payment

    Common Stock

    2023-06-30$4.10/sh157$64425,750 total
Footnotes (1)
  • [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1
  • filerCIK 0001727809

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:32 PM ET
Size
5.1 KB